Today: 8 June 2026
Goldman Sachs stock edges up after Apple Card exit adds $0.46 to Q4 EPS — what to watch next
9 January 2026
2 mins read

Goldman Sachs stock edges up after Apple Card exit adds $0.46 to Q4 EPS — what to watch next

New York, January 9, 2026, 12:57 ET — Regular session

  • GS up roughly 0.5% around midday after Apple Card transition details surfaced
  • Apple Card deal seen adding roughly $0.46 to Q4 EPS, though net revenue takes a hit from write-downs and termination costs
  • Attention turns to Jan. 15 earnings and any commentary on deal fees, trading and costs

Goldman Sachs shares nudged up Friday after the bank said it has a deal to move the Apple Card program to JPMorgan Chase’s Chase, which JPMorgan and Apple said would shift more than $20 billion in card balances to Chase once the transition is finished. Goldman was up 0.5% at $939.12 by midday, versus a 0.1% gain for the Financial Select Sector SPDR ETF; JPMorgan and Morgan Stanley also traded higher. Goldman said the exit should lift fourth-quarter diluted earnings per share by about 46 cents, reflecting a $2.48 billion release of loan-loss reserves — money set aside for expected credit losses — partially offset by a $2.26 billion hit to net revenue from loan write-downs and contract-ending costs plus $38 million of expenses; CEO David Solomon said it “substantially completes” the narrowing of its consumer focus. Reuters

Timing is key. Big U.S. banks start reporting next week, with Goldman up on Jan. 15. Investors want to see whether a rebound in M&A and underwriting actually flowed through to fees, and whether markets revenue held up into year-end. A Reuters preview pegged global investment banking revenue up 15% in 2025 to almost $103 billion, and put global M&A volume at $5.1 trillion, up 42% from 2024. Stephen Biggar, a banking analyst at Argus Research, called the quarter a “perfect recipe” for investment banking revenue. Reuters

A regulatory filing showed Goldman tweaked its segment reporting beginning in the fourth quarter, shifting transaction banking into Global Banking & Markets and narrowing how it reports consumer-related activity within Platform Solutions. The bank said it recast segment results back to its 2021 fiscal year for comparability, a change that could alter how analysts follow Platform Solutions as Apple Card runs off.

On the dealmaking front, Goldman was also tapped alongside UBS on a planned initial public offering of CK Hutchison’s A.S. Watson unit, Bloomberg News reported, citing people familiar with the matter. Hong Kong logged its strongest IPO year since 2021 in 2025, with 114 new listings raising $36.5 billion, according to LSEG data cited by Reuters.

Macro could still tug the tape. A Reuters Week Ahead report said bank results and Tuesday’s U.S. consumer price index report will compete for investor attention, and it pointed to rising focus on what banks say about household finances. “The banks are going to be telling you something … pretty important because they’re on the front lines,” said Jack Janasiewicz, a portfolio manager at Natixis Investment Managers. Reuters

But the Apple Card handoff still needs regulatory approvals and will take time, keeping Goldman on the hook for any swing in consumer credit performance until the accounts move. A sharper-than-expected jump in delinquencies, or another market wobble that freezes IPOs and deal talks, would dent the fee story investors have been leaning on into earnings.

Goldman is set to report fourth-quarter results on Thursday, Jan. 15, with the release expected around 7:30 a.m. ET followed by a conference call at 9:30 a.m. ET, the bank said. Traders will be tuned in for signs of how quickly Platform Solutions shrinks, and whether momentum in advisory and underwriting can make up for any softer patches in wealth and financing.

Stock Market Today

  • Micron's Stock Surges on Strong Memory Sector Outlook
    June 8, 2026, 9:57 AM EDT. Micron Technology's stock rebounded sharply, driven by renewed optimism in the memory chip sector. Analysts highlight that long-term supply agreements are improving memory companies' earnings prospects. These contracts, which secure steady revenue streams over extended periods, are seen as a positive development amid volatile market conditions. The upbeat sentiment reflects confidence that the memory trade remains robust despite past challenges. Investors are responding to these factors, signaling that the demand for memory chips continues to support Micron's growth potential.

Latest articles

Corning Wins Amazon AI Fiber Deal; GLW Faces Next Hurdle

Corning Wins Amazon AI Fiber Deal; GLW Faces Next Hurdle

8 June 2026
Amazon’s new multibillion-dollar supply deal makes Corning a key fiber provider for U.S. data centers, but with shares up 305% in 12 months and investors already pricing in big AI wins, the stock was little changed at $177.58 premarket as risks of factory delays and high expectations loom.
BlackBerry Shares Stall After QNX Push

BlackBerry Stock Moves in Pre-Market Ahead of June Test

8 June 2026
BlackBerry’s U.S. shares rose 2.34% in premarket trading to $9.63 after Friday’s 8.99% drop, but with analyst targets averaging just $4.98, investors are betting on QNX growth and secure-communications wins ahead of June 25 earnings; any disappointment could hit the stock hard.
Micron Technology Stock Surges as AI Memory Shortage Puts MU at Center of Chip Rally

Micron Shares Edge Up in Premarket; Investors Await Next AI Test

8 June 2026
Micron surged 8.2% to $935.07 in Nasdaq premarket after Friday’s $127 billion rout, as investors cheered Nvidia’s confirmation it will keep sourcing high-bandwidth memory from Micron and Samsung, easing fears SK Hynix would become exclusive supplier; Cantor Fitzgerald raised its price target to $1,500, with Micron’s next earnings report due June 24.
Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

8 June 2026
Tango shares soared up to 48% in premarket trading after reporting a 92% objective response rate and 90% six-month progression-free survival in a 12-patient pancreatic cancer trial, with plans to advance the vopimetostat-daraxonrasib combo to Phase 3 testing in first-line MTAP-deleted pancreatic cancer.
Nokia stock rises after Hisense patent deal ends litigation; investors watch next moves
Previous Story

Nokia stock rises after Hisense patent deal ends litigation; investors watch next moves

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14
Next Story

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Go toTop